| dc.description.abstract | The coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global public health, demanding
urgent action and causing unprecedented worldwide change in a short space of time. This disease has devastated
economies, infringed on individual freedoms, and taken an unprecedented toll on healthcare systems worldwide.
As of 1 April 2020, over a million cases of COVID-19 have been reported in 204 countries and territories,
resulting in more than 51,000 deaths. Yet, against the backdrop of the COVID-19 pandemic, lies an older,
insidious disease with a much greater mortality. Tuberculosis (TB) is the leading cause of death by a single
infectious agent and remains a potent threat to millions of people around the world. We discuss the differences
between the two pandemics at present, consider the potential impact of COVID-19 on TB case management, and
explore the opportunities that the COVID-19 response presents for advancing TB prevention and control now and
in future. | en_US |
